Bridging the Gap in EoE: Innovative Strategies for Seamless Transition of Care

Join leading experts in EoE, Thomas Greuter, MD, Edoardo Vincenzo Savarino, MD, PhD, and Carla Giordano, MD, PhD, as they use a case-based approach to explore the impact of chronic type 2 inflammation in EoE and outline strategies for optimizing transition of care and monitoring disease progression. They review the latest clinical evidence on therapeutic management and share insights from their own practice to support shared decision-making in the long-term care of EoE.

MD, PhD

Edoardo Vincenzo Savarino +2 more

Learning objectives

Recognize the clinical consequences of chronic underlying type 2 inflammation in EoE
Learn approaches to monitor disease, optimize care, and identify risks of disease progression
Review the latest clinical evidence for therapeutic options in EoE
Discuss how to tailor long-term EoE care based on individual patient needs

About these experts

Gastroenterology

MD, PhD

Edoardo Vincenzo Savarino

Associate Professor of Gastroenterology University of Padua - Medical and Surgical School Padua, Italy

Gastroenterology

Thomas Greuter

Professor of Gastroenterology and Hepatology Università della Svizzera italiana Lugano, Switzerland

Gastroenterology

MD, PhD

Carla Giordano

Professor of Anatomical Pathology Department of Radiology, Oncology, and Pathology Sapienza University of Rome Rome, Italy

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: MacauChange country/region